Bristol Myers Squibb today announced that the company will participate in two upcoming investor conferences in May 2024.
Ben Hickey, President, RayzeBio, Head of Mirati, will take part in a.
Advanced RP-L102 for Fanconi Anemia towards regulatory reviews; EMA accepted MAA for review and BLA submission anticipated in the first half of 2024
Continued preparations to launch LV portfolio.
West To Participate In Upcoming Investor Conference menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced.
SAN DIEGO, Sept. 05, 2023 ResMed today announced its participation in two upcoming conferences. Mick Farrell, chief executive officer and chair of the board, and Brett Sandercock, chief.